Expression of domains for protein–protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability. (October 2014)
- Record Type:
- Journal Article
- Title:
- Expression of domains for protein–protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability. (October 2014)
- Main Title:
- Expression of domains for protein–protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability
- Authors:
- Jordheim, Lars Petter
Cros‐Perrial, Emeline
Matera, Eva‐Laure
Bouledrak, Karima
Dumontet, Charles - Abstract:
- <abstract abstract-type="main" id="cep12282-abs-0001"> <title>Summary</title> <p>Nucleotide excision repair (NER) is involved in the repair of DNA damage caused by platinum derivatives and has been shown to decrease the cytotoxic activity of these drugs. Because protein–protein interactions are essential for NER activity, we transfected human cancer cell lines (A549 and HCT116) with plasmids coding the amino acid sequences corresponding to the interacting domains between excision repair cross‐complementation group 1 (ERCC1) and xeroderma pigmentosum, complementation group A (XPA), as well as ERCC1 and xeroderma pigmentosum, complementation group F (XPF), all NER proteins. Using the 3‐(4, 5‐dimethyl‐2 thiazoyl)‐2, 5‐diphenyl‐2H‐tetrazolium bromide (MTT) assay and annexin V staining, we showed that transfected A549 cells were sensitized 1.2–2.2‐fold to carboplatin and that transfected HCT116 cells were sensitized 1.4–5.4‐fold to oxaliplatin <italic>in vitro</italic>. In addition, transfected cells exhibited modified <italic>in vivo</italic> sensitivity to the same drugs. Finally, in particular cell models of the interaction between ERCC1 and XPF, DNA repair was decreased, as evidenced by increased phosphorylation of the histone 2AX after exposure to mitomycin C, and genomic instability was increased, as determined by comparative genomic hybridization studies. The results indicate that the interacting peptides act as dominant negatives and decrease NER activity through<abstract abstract-type="main" id="cep12282-abs-0001"> <title>Summary</title> <p>Nucleotide excision repair (NER) is involved in the repair of DNA damage caused by platinum derivatives and has been shown to decrease the cytotoxic activity of these drugs. Because protein–protein interactions are essential for NER activity, we transfected human cancer cell lines (A549 and HCT116) with plasmids coding the amino acid sequences corresponding to the interacting domains between excision repair cross‐complementation group 1 (ERCC1) and xeroderma pigmentosum, complementation group A (XPA), as well as ERCC1 and xeroderma pigmentosum, complementation group F (XPF), all NER proteins. Using the 3‐(4, 5‐dimethyl‐2 thiazoyl)‐2, 5‐diphenyl‐2H‐tetrazolium bromide (MTT) assay and annexin V staining, we showed that transfected A549 cells were sensitized 1.2–2.2‐fold to carboplatin and that transfected HCT116 cells were sensitized 1.4–5.4‐fold to oxaliplatin <italic>in vitro</italic>. In addition, transfected cells exhibited modified <italic>in vivo</italic> sensitivity to the same drugs. Finally, in particular cell models of the interaction between ERCC1 and XPF, DNA repair was decreased, as evidenced by increased phosphorylation of the histone 2AX after exposure to mitomycin C, and genomic instability was increased, as determined by comparative genomic hybridization studies. The results indicate that the interacting peptides act as dominant negatives and decrease NER activity through inhibition of protein–protein interactions.</p> </abstract> … (more)
- Is Part Of:
- Clinical and experimental pharmacology and physiology. Volume 41:Number 10(2014:Oct.)
- Journal:
- Clinical and experimental pharmacology and physiology
- Issue:
- Volume 41:Number 10(2014:Oct.)
- Issue Display:
- Volume 41, Issue 10 (2014)
- Year:
- 2014
- Volume:
- 41
- Issue:
- 10
- Issue Sort Value:
- 2014-0041-0010-0000
- Page Start:
- 817
- Page End:
- 824
- Publication Date:
- 2014-10
- Subjects:
- Clinical pharmacology -- Periodicals
Pharmacology, Experimental -- Periodicals
Physiology, Experimental -- Periodicals
Physiology, Pathological -- Periodicals
615.1 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=cep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1440-1681.12282 ↗
- Languages:
- English
- ISSNs:
- 0305-1870
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.252000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4109.xml